Group | Case, n | Death, n (%) | rs1927911 | rs10512263 | ||||
---|---|---|---|---|---|---|---|---|
GA/AA: GG | HR (95% CI)a | p-value | CT/CC: TT | HR (95% CI)a | P-value | |||
Age | ||||||||
< 64 | 224 | 130 (0.58) | 142/82 | 1.64 (1.13,2.38) | 0.009 | 97/127 | 1.34 (0.95,1.90) | 0.099 |
≥ 64 | 236 | 156 (0.66) | 153/83 | 1.04 (0.75,1.45) | 0.817 | 94/142 | 1.19 (0.86,1.64) | 0.286 |
Gender | ||||||||
Male | 338 | 214 (0.63) | 216/122 | 1.36 (1.03,1.81) | 0.033 | 145/193 | 1.43 (1.09,1.87) | 0.010 |
Female | 122 | 72 (0.64) | 79/43 | 1.08 (0.65,1.80) | 0.754 | 46/76 | 1.26 (0.76,2.08) | 0.365 |
Clinical stage | ||||||||
T1–T2 | 159 | 42 (0.26) | 102/57 | 1.36 (0.70,2.66) | 0.367 | 60/99 | 2.61 (1.40,4.86) | 0.003 |
T3–T4 | 301 | 244 (0.81) | 193/108 | 1.21 (0.93,1.58) | 0.160 | 131/170 | 1.04 (0.80,1.34) | 0.784 |
Tumor site | ||||||||
Cardiac | 132 | 87 (0.66) | 91/41 | 1.07 (0.67,1.71) | 0.768 | 54/78 | 1.47 (0.94,2.31) | 0.094 |
Non-cardiac | 328 | 199 (0.61) | 204/124 | 1.34 (1.00,1.80) | 0.050 | 137/191 | 1.36 (1.02,1.80) | 0.034 |